Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

(2016) D. Williams Parsons et al.   JAMA Oncology

Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors

(2016) Marian H. Harris et al.   JAMA Oncology

Improving the outcome for children with cancer: Development of targeted new agents

(2015) Peter C. Adamson   CA-A CANCER JOURNAL FOR CLINICIANS

Translating genomic discoveries to the clinic in pediatric oncology

(2015) Julia Glade Bender et al.   CURRENT OPINION IN PEDIATRICS

Improving Patient Outcomes With Cancer Genomics

(2015) Robert W. Schnepp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth

(2015) Rajen J. Mody et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine

(2015) Amanda J. Redig et al.   JOURNAL OF CLINICAL ONCOLOGY

NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era:

(2015) Caroline McNeil   JNCI-Journal of the National Cancer Institute

Germline Mutations in Predisposition Genes in Pediatric Cancer

(2015) Jinghui Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

(2015) David M. Hyman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research

(2015) Jennifer A. Oberg et al.   PEDIATRIC BLOOD & CANCER

Is Whole-Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients With Solid Tumors

(2015) Laurence B. McCullough et al.   PEDIATRIC BLOOD & CANCER

Post-relapse survival in patients with Ewing sarcoma

(2015) Stefano Ferrari et al.   PEDIATRIC BLOOD & CANCER

NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era:

(2015) Caroline McNeil   JNCI-Journal of the National Cancer Institute

Genomic testing in cancer: Patient knowledge, attitudes, and expectations

(2014) Phillip S. Blanchette et al.   CANCER

Declining childhood and adolescent cancer mortality

(2014) Malcolm A. Smith et al.   CANCER

Clinical Tumor Sequencing: An Incidental Casualty of the American College of Medical Genetics and Genomics Recommendations for Reporting of Incidental Findings

(2014) D. Williams Parsons et al.   JOURNAL OF CLINICAL ONCOLOGY

Physicians' Attitudes About Multiplex Tumor Genomic Testing

(2014) Stacy W. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

(2014) Benjamin J. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Parents' Preferences for Return of Results in Pediatric Genomic Research

(2014) S.I. Ziniel et al.   Public Health Genomics

Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients

(2014) Sarah Scollon et al.   Genome Medicine

Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience

(2013) Sarah E. S. Leary et al.   CANCER

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

(2013) Fiona A Miller et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Future of Clinical Genomics in Pediatric Oncology

(2013) Katherine A. Janeway et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

(2013) Yael P Mossé et al.   LANCET ONCOLOGY

Effects of informed consent for individual genome sequencing on relevant knowledge

(2012) KA Kaphingst et al.   CLINICAL GENETICS

Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic Testing

(2012) Stacy W. Gray et al.   Journal of Oncology Practice

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

(2011) H. M. Kantarjian et al.   BLOOD

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

(2011) Edith A. Perez et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Motivations and Perceptions of Early Adopters of Personalized Genomics: Perspectives from Research Participants

(2011) S.E. Gollust et al.   Public Health Genomics

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic Review of Psychosocial Benefits and Harms of Genetic Testing

(2010) Lynn Rew et al.   Issues in Mental Health Nursing

Public understandings of genetics and health

(2009) CM Condit   CLINICAL GENETICS

Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

(2008) Odile Oberlin et al.   JOURNAL OF CLINICAL ONCOLOGY